This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
CNO Financial Hikes Dividend, Announces Share Buyback Plan
by Zacks Equity Research
The board of directors of CNO Financial Group (CNO) recently announced a dividend hike along with a share repurchase program.
FBL Financial (FFG) and Units' Ratings Upgraded by A.M. Best
by Zacks Equity Research
FBL Financial Group, Inc. (FFG) and its units recently received rating action from credit rating giant A.M. Best.
Anthem Finally Walks Away from Cigna Merger, Seeks Charges
by Zacks Equity Research
Anthem Inc. (ANTM) has officially terminated its merger with Cigna.
AIG May Name New CEO: Will this Boost its Turnaround Story?
by Zacks Equity Research
American International Group, Inc. (AIG) is very close to naming its new CEO.
Company News for May 08, 2017
by Zacks Equity Research
Companies in the News are: ATVI,CI,CTSH,SHAK
Cigna (CI) Beats on Q1 Earnings and Revenues, Guides Up
by Zacks Equity Research
Cigna (CI) earnings of $2.77 per share, comfortably beating the Zacks Consensus Estimate of $2.44.
Trumpcare Gets House Support: What Next?
by Arpita Dutt
Although the House of Representatives voted to repeal Obamacare, will the Senate vote for Trumpcare in its current form?
Cigna (CI) Q1 Earnings & Revenues Beat, Ups Outlook
by Zacks Equity Research
Cigna (CI) reported net operating earnings per share of $2.77, comfortably beating the Zacks Consensus Estimate of $2.44
Insurance Stocks to Watch for Earnings on May 5: BRK.B, CI
by Zacks Equity Research
Let's find out how these two insurers - BRK.B, CI - might perform when they release their quarterly numbers on May 5.
Cigna (C) Q1 Earnings: Is Disappointment in the Cards?
by Zacks Equity Research
Our proven model does not conclusively show that Cigna (CI) is likely to beat on earnings this quarter.
Cigna Hurt by CMS Control, Blocked Deal, Yet on Growth Path
by Zacks Equity Research
Cigna Corp. (CI) has been in troubled waters with the restriction imposed by the CMS, friction with Anthem, but has managed to carry on well.
Medicare Rates Rise More Than Expected, Insurers Breathe Easy
by Zacks Equity Research
The CMS has decided to raise 2018 Medicare Advantage more than expected.
Cigna (CI) Trending Up in 2017: What's Driving the Stock?
by Zacks Equity Research
Shares of Cigna Corp. (CI) have significantly outperformed the Zacks categorized Health Maintenance Organization industry.
Humana Poised to Grow on Government Business, Strong Capital
by Zacks Equity Research
Humana, Inc. (HUM) stock has long been an investor favorite owing to its strong fundamentals.
Health Insurers Hit 52-Week Highs: What's Behind the Rise?
by Zacks Equity Research
The rally in the stock is believed to be have occurred from the repeal and replace plan unveiled by the Trump administration.
Cigna (CI) Up 2.5% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Cigna (CI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cigna Ties Up with DaVita Unit for New Healthcare Plans
by Zacks Equity Research
Cigna Corporation (CI) recently announced a definitive agreement with HealthCare Partners, a division of DaVita Inc. (DVA).
Cigna-Anthem Merger Conflict Continues with Countersuit
by Zacks Equity Research
Cigna (CI)-Anthem (ANTM) fight has reached a stage where the focus is on the breakup fee and damages rather than the sealing of the deal.
Health Insurers' Courtship Ends on Valentine's Day
by Zacks Equity Research
More than one and a half years of courtship between Anthem Inc. (ANTM) and Cigna Corp. (CI) as well as Aetna Inc. (AET) and Humana Inc. (HUM) ended yesterday.
Cigna Wants Divorce from Anthem Deal, Sues for Nearly $15 Billion
by Madeleine Johnson
On the heels of Aetna's (AET) and Humana's (HUM) announcement, health insurance competitors Cigna (CI) and Anthem (ANTM) also announced that their merger deal is done-zo on Tuesday.
Aetna, Humana Call Off $34 Billion Courtship in Bad Start to Valentine's Day
by Madeleine Johnson
On Tuesday, health insurance giants Aetna (AET) and Humana (HUM) announced that they have called off their merger agreement after a federal court decision struck down the deal as anticompetitive.
Is Cigna (CI) a Great Stock for Value Investors?
by Zacks Equity Research
Cigna (CI) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and U.S. Healthcare Providers iShares ETF
by Zacks Equity Research
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and U.S. Healthcare Providers iShares ETF
Anthem-Cigna Merger Receives a Blow from Federal Judge
by Zacks Equity Research
As anticipated, the merger between Anthem Inc. (ANTM) and Cigna Corp. (CI) saw the same fate as that of Aetna and Humana which was blocked last month.
Cigna (CI) Beats Earnings and Revenue Estimates in Q4
by Zacks Equity Research
Cigna Corp. (CI) reported fourth-quarter 2016 operating net earnings of $1.87 per share, which surpassed the Zacks Consensus Estimate of $1.74. However, earnings remained flat year over year.